|Title:||Presence of Tablet Remnants of Nevirapine Extended-Release in Stools and Its Impact on Virological Outcome in HIV-1-Infected Patients: A Prospective Cohort Study||Authors:||Lee, Yi-Chieh
|Issue Date:||2015||Source:||PloS one||Journal Volume:||10||Journal Issue:||10||Abstract:||
Nevirapine extended-release (NVP-XR) taken once daily remains an effective antiretroviral agent for patients infected with HIV-1 strains that do not harbor resistance mutations. Presence of tablet remnants of NVP XR in stools was reported in 1.19% and 3.05% of subjects in two clinical trials. However, the prevalence may have been underestimated because the information was retrospectively collected in the studies.
|Appears in Collections:||臨床藥學研究所|
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.